Christopher Powala
Principal investigator, leads NFlection Therapeutics, Inc..
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$300KFederal grants as PI1 awards
1Patents grantedLatest May 27, 2025
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
1 awards · $300K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| — | NIH | SBIR Phase I TOPIC 386: PROOF OF CONCEPT FOR A TOPICAL MEK INHIBITOR AS A CHEMOPREVENTIVE AGENT FOR SQUAMOUS CELL CARCINOMA IN HIGH RISK ORGAN TRANSPLANT PATIENTS | $300K | NFlection Therapeutics, Inc. |
2 patents as inventor
- US 12310950NFlection Therapeutics, Inc.May 27, 2025
- US NFlection Therapeutics, Inc.—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#3,470
Awards as PI#2,540
Patents#284
Companies
- NFlection Therapeutics, Inc.Leads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.